• Home
  • Study Details
Open

Helping with Metastatic Cancer: New Treatment Study

We are looking for ways to help people with certain types of cancer that spread and become very serious. SolveTx has created a new treatment to target these cancers. If you join, you will have some check-ups before and after the treatment and get the study treatment. We'll make sure to keep an eye on how you're doing for about 3 years after your treatment finishes.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide)

What will be asked of you

When you come in for your first visit, you'll go over and sign a form saying you agree to join the study. You'll also talk about your health history and see if you can join the study by doing some simple health checks. You'll give samples like blood and urine. During the study, you'll get the study medicine through a small tube in your arm once every 3 weeks. You'll come back on some days after getting the medicine for more health checks. After your last medicine, we'll keep track of how you're doing for about 30 days, and then every 3 to 6 months for up to 3 years. We'll collect information about any other treatments you're getting and how you're feeling through check-ins at the clinic, or by phone, email, or mail. Let us know about any new feelings or changes in your health during the study.

Incentives

You will get free study medication, doctor visits, and lab tests related to the study.

In-person visits:
14-20
Phone or online visits:
1
Total length of participation:
Approximately 36 months

Looking for Specific Volunteers

Able to participate:

  • Confirmed diagnosis of solid tumor as documented in medical records
  • Presence of metastatic disease that has progressed during or following previous treatment
  • Completion of all previous therapy for the treatment of cancer ≥1 week before study drug administration
  • Patients who are not pregnant

Not eligible if:

  • Patients who are taking part in another treatment or imaging clinical trial at the same time
  • Patients who are pregnant or breastfeeding

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Sid Sheth
Medicine- Oncology

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Phase 1 Trials (all cancers))

IRB Number

25-2106

ClinicalTrials.gov

NCT07108114

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research